Document Detail

Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
MedLine Citation:
PMID:  21038414     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: Conjugation is essential for the anticholestatic effect of norUDCA in a model of hepatocellular cholestasis. Combined therapy with UDCA and norUDCA may be superior to UDCA or norUDCA monotherapy in biliary disorders in which hepatocyte as well as cholangiocyte dysfunction contribute to disease progression.
Gerald U Denk; Silvia Maitz; Ralf Wimmer; Christian Rust; Pietro Invernizzi; Sacha Ferdinandusse; Wim Kulik; Andrea Fuchsbichler; Peter Fickert; Michael Trauner; Alan F Hofmann; Ulrich Beuers
Related Documents :
1278184 - Acrodermatitis enteropathica: recent findings concerning clinical features, pathogenesi...
8477964 - Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.
9717724 - Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinfla...
1583874 - 3 beta-hydroxy-delta 5-c27-steroid dehydrogenase deficiency; effect of chenodeoxycholic...
11886294 - N-arylation of primary and secondary aliphatic amines on solid supports.
2010904 - A chemically defined medium for slime production by coagulase-negative staphylococci.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Hepatology (Baltimore, Md.)     Volume:  52     ISSN:  1527-3350     ISO Abbreviation:  Hepatology     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-01     Completed Date:  2010-11-24     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  8302946     Medline TA:  Hepatology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1758-68     Citation Subset:  IM    
Department of Medicine II, Klinikum Großhadern, University of Munich, Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apoptosis / drug effects
Bile / secretion
Bile Acids and Salts / metabolism
Carcinoma, Hepatocellular / pathology
Cholangitis / drug therapy
Cholestasis / chemically induced*
Chromatography, Gas
Hepatoblastoma / pathology
Liver / drug effects,  metabolism
Liver Diseases / etiology*
Liver Neoplasms / pathology
Rats, Sprague-Dawley
Taurine / metabolism
Taurolithocholic Acid / adverse effects*
Ursodeoxycholic Acid / therapeutic use
Reg. No./Substance:
0/Bile Acids and Salts; 107-35-7/Taurine; 128-13-2/Ursodeoxycholic Acid; 516-90-5/Taurolithocholic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experienc...
Next Document:  The fractalkine receptor CX?CR1 protects against liver fibrosis by controlling differentiation and s...